Literature DB >> 7307340

Demonstration of 11S IgA antibody to spermatozoa in human seminal fluid.

S S Witkin, G Zelikovsky, R A Good, N K Day.   

Abstract

Spontaneous sperm agglutination was observed in the ejaculate of a 39-year-old male (patient Z). Using an enzyme-linked immunosorbent assay (ELISA) with spermatozoa fixed to wells of a microtitre plate it was determined that IgA was associated with patient Z's spermatozoa but not with a pooled sample of spermatozoa from fertile men Z's seminal fluid agglutinated human spermatozoa (titre 1:16). In contrast, no sperm-agglutinating or immobilizing activity was present in the patient's serum. Agglutination was prevented by preincubation of the seminal fluid with anti-IgA antibody but not with anti-IgA antibody. IgG from Z's seminal fluid readily bound to human spermatozoa, as determined by the ELISA assay. IgA from a pool of seminal fluids from fertile men or from 18 human sera bound to spermatozoa to a much lesser extent. By sucrose-gradient velocity centrifugation it was demonstrated that the anti-sperm IgA in patient Z's seminal fluid was 11S. Finally, antibody to secretory component removed the anti-sperm IgA from Z's seminal fluid. These data provide evidence that secretory IgA with anti-sperm activity is produced in the male genital tract. Furthermore, a new methodology is presented for the determination of antibodies to spermatozoa.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7307340      PMCID: PMC1537340     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  10 in total

1.  Methods for the detection of antibodies against mammalian spermatozoa. II. A gelatin agglutination test.

Authors:  S KIBRICK; D L BELDING; B MERRILL
Journal:  Fertil Steril       Date:  1952 Sep-Oct       Impact factor: 7.329

2.  Ribonuclease-sensitive DNA-synthesizing complex in human sperm heads and seminal fluid.

Authors:  S S Witkin; G C Korngold; A Bendich
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

3.  Sperm antibodies in serum and seminal plasma.

Authors:  S Husted; T Hjort
Journal:  Int J Fertil       Date:  1975

4.  The origin of immunoglobulins in semen.

Authors:  P Rümke
Journal:  Clin Exp Immunol       Date:  1974-06       Impact factor: 4.330

5.  Components of human split ejaculates. I. Spermatozoa, fructose, immunoglobulins, albumin, lactoferrin, transferrin and other plasma proteins.

Authors:  P F Tauber; L J Zaneveld; D Propping; G F Schumacher
Journal:  J Reprod Fertil       Date:  1975-05

6.  Antigenic status of semen from the viewpoints of the female and male.

Authors:  A E Beer; W B Neaves
Journal:  Fertil Steril       Date:  1978-01       Impact factor: 7.329

7.  In vivo bound immunoglobulins in the human prostate--their identification and possible significance.

Authors:  R J Ablin; W A Soanes; M J Gonder
Journal:  Z Immunitatsforsch Exp Klin Immunol       Date:  1972-10

8.  Secretory IgA in seminal fluid.

Authors:  D T Uehling
Journal:  Fertil Steril       Date:  1971-11       Impact factor: 7.329

9.  The sperm-cervical mucus contact test: a preliminary report.

Authors:  J Kremer; S Jager
Journal:  Fertil Steril       Date:  1976-03       Impact factor: 7.329

10.  Demonstration of IgG Fc receptors on spermatozoa and their utilization for the detection of circulating immune complexes in human serum.

Authors:  S S Witkin; S K Shahani; S Gupta; R A Good; N K Day
Journal:  Clin Exp Immunol       Date:  1980-09       Impact factor: 4.330

  10 in total
  2 in total

1.  Relation between antisperm antibodies and the rate of fertilization of human oocytes in vitro.

Authors:  S S Witkin; D Viti; S S David; J Stangel; Z Rosenwaks
Journal:  J Assist Reprod Genet       Date:  1992-02       Impact factor: 3.412

2.  Sperm-related antigens, antibodies, and circulating immune complexes in sera of recently vasectomized men.

Authors:  S S Witkin; G Zelikovsky; A M Bongiovanni; N Geller; R A Good; N K Day
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.